<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04743817</url>
  </required_header>
  <id_info>
    <org_study_id>SK-0119</org_study_id>
    <nct_id>NCT04743817</nct_id>
  </id_info>
  <brief_title>Feasibility Evaluation of OtoSet</brief_title>
  <official_title>Feasibility Evaluation of the OtoSet - Ear Cleaning System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SafKan</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SafKan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single center study. 100 ears are planned (up to 100 patients). Each subject will&#xD;
      have one or both ears cleaned with OtoSet. The subject's level of earwax will be evaluated&#xD;
      before and after by an evaluator.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center study. 100 ears are planned (up to 100 patients). Each subject will&#xD;
      have one or both ears cleaned with OtoSet. The subject's level of earwax will be evaluated&#xD;
      before and after by an evaluator.&#xD;
&#xD;
      Screening data will be reviewed to determine subject eligibility. Subjects who meet all&#xD;
      inclusion criteria and none of the exclusion criteria will be entered into the study.&#xD;
&#xD;
      Total duration of subject participation will be 1 day with a follow up call within 2-4 days&#xD;
      after the procedure. Total duration of the study is expected to be 3 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy as Assessed by Occlusion Scale</measure>
    <time_frame>Treatment Visit (Day 1) (pre- to post-procedure)</time_frame>
    <description>Improvement of 1.0 on the Degree of Occlusion Scale (4 point scale) pre- and post-procedure evaluation (score 0 = no occlusion; 3 = complete occlusion)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety as Assessed by Adverse Events</measure>
    <time_frame>Treatment Visit (Day 1) through follow-up call (Day 2-4)</time_frame>
    <description>Incidence of adverse events with severity defined using the National Cancer Institute's Common Terminology Criteria for Adverse Events (4 point scale) (1 = mild; 4 = life-threatening)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cerumen Impaction of Both Ears</condition>
  <arm_group>
    <arm_group_label>OtoSet - Ear Cleaning Sytem</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OtoSet - Ear Cleaning System</intervention_name>
    <description>Up to five (5) cleaning cycles using the OtoSet - Ear Cleaning System</description>
    <arm_group_label>OtoSet - Ear Cleaning Sytem</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Mild (1), Moderate (2), or Complete (3) occlusion of the ear canal based on the Degree&#xD;
             of Occlusion Scale in one or both ears&#xD;
&#xD;
          -  Informed consent obtained from subject or subject's legal representative and ability&#xD;
             for subject to comply with the requirements of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of a condition or abnormality that in the opinion of the Investigator would&#xD;
             compromise the safety of the patient of the quality of data&#xD;
&#xD;
          -  Subject has life threatening illness&#xD;
&#xD;
          -  Subject has immune deficiency&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felice Anderson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eclipse Clinical Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eclipse Clinical Research</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85745</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>520-647-9926</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 3, 2021</study_first_submitted>
  <study_first_submitted_qc>February 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2021</study_first_posted>
  <last_update_submitted>February 3, 2021</last_update_submitted>
  <last_update_submitted_qc>February 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

